agilon health inc. Quarterly Balance Sheets Chart
Quarterly
|
Annual
agilon health inc. Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||
| current assets: | |||||||||||||||||
| cash and cash equivalents | 171,416,000 | 136,941,000 | 188,231,000 | 148,161,000 | 109,490,000 | 111,706,000 | 107,570,000 | 168,339,000 | 394,190,000 | 497,070,000 | 551,287,000 | 668,574,000 | 1,021,754,000 | 1,040,039,000 | 1,081,601,000 | 1,109,372,000 | 105,289,000 |
| restricted cash and equivalents | 1,682,000 | 5,629,000 | 5,629,000 | 6,846,000 | 6,844,000 | 6,759,000 | 10,204,000 | 10,204,000 | 10,610,000 | 13,192,000 | 15,085,000 | 14,470,000 | 14,781,000 | 14,302,000 | 16,343,000 | 14,202,000 | |
| marketable securities | 155,585,000 | 230,143,000 | 211,737,000 | 244,766,000 | 291,622,000 | 307,359,000 | 380,773,000 | 395,878,000 | 422,492,000 | 411,901,000 | 407,993,000 | 285,590,000 | |||||
| receivables | 1,047,164,000 | 1,239,603,000 | 1,017,040,000 | 1,368,349,000 | 1,437,040,000 | 1,571,143,000 | 942,461,000 | 1,345,711,000 | 1,004,856,000 | 497,574,000 | 637,731,000 | 607,632,000 | 571,869,000 | 293,407,000 | 342,500,000 | 338,359,000 | 288,827,000 |
| prepaid expenses and other current assets | 78,495,000 | 42,353,000 | 35,137,000 | 44,854,000 | 39,012,000 | 39,757,000 | 42,513,000 | 36,512,000 | 44,697,000 | 34,119,000 | 24,067,000 | 24,528,000 | 19,847,000 | 18,968,000 | 14,463,000 | 15,740,000 | 9,314,000 |
| total current assets | 1,452,660,000 | 1,650,722,000 | 1,457,774,000 | 1,811,759,000 | 1,884,010,000 | 2,036,809,000 | 1,480,076,000 | 1,956,644,000 | 1,876,439,000 | 1,451,274,000 | 1,634,270,000 | 1,601,409,000 | 1,627,940,000 | 1,367,195,000 | 1,452,866,000 | 1,479,814,000 | 417,632,000 |
| property and equipment | 27,410,000 | 28,088,000 | 28,169,000 | 28,194,000 | 27,821,000 | 27,539,000 | 27,576,000 | 26,203,000 | 22,132,000 | 20,050,000 | 17,940,000 | 15,808,000 | 12,526,000 | 9,161,000 | 6,462,000 | 4,589,000 | 4,799,000 |
| intangible assets | 65,595,000 | 68,187,000 | 72,771,000 | 73,412,000 | 74,821,000 | 72,076,000 | 63,769,000 | 92,657,000 | 92,712,000 | 67,680,000 | 60,602,000 | 62,505,000 | 53,709,000 | 55,398,000 | 58,147,000 | 58,663,000 | 61,609,000 |
| goodwill | 24,133,000 | 24,133,000 | 24,133,000 | 24,133,000 | 24,133,000 | 24,133,000 | 24,133,000 | 62,387,000 | 62,140,000 | 41,540,000 | 41,540,000 | 41,540,000 | 41,540,000 | 41,540,000 | 41,540,000 | 41,540,000 | 41,540,000 |
| other assets | 143,097,000 | 161,731,000 | 151,136,000 | 153,913,000 | 152,530,000 | 155,906,000 | 145,312,000 | 140,184,000 | 116,846,000 | 116,924,000 | 116,083,000 | 119,260,000 | 119,496,000 | 112,958,000 | 126,105,000 | 117,128,000 | 47,259,000 |
| total assets | 1,712,895,000 | 1,932,861,000 | 1,733,983,000 | 2,091,411,000 | 2,163,315,000 | 2,316,463,000 | 1,740,866,000 | 2,278,075,000 | 2,170,269,000 | 1,697,468,000 | 1,870,435,000 | 1,840,522,000 | 1,855,211,000 | 1,586,252,000 | 1,685,120,000 | 1,701,734,000 | 574,038,000 |
| liabilities and stockholders’ equity | |||||||||||||||||
| current liabilities: | |||||||||||||||||
| medical claims and related payables | 1,042,257,000 | 1,113,084,000 | 931,664,000 | 1,190,665,000 | 1,097,664,000 | 1,266,651,000 | 737,724,000 | 1,005,762,000 | 745,557,000 | 346,727,000 | 490,840,000 | 458,038,000 | 472,323,000 | 239,014,000 | 288,121,000 | 300,981,000 | 276,984,000 |
| accounts payable and accrued expenses | 171,886,000 | 226,693,000 | 280,899,000 | 252,497,000 | 233,182,000 | 290,563,000 | 222,052,000 | 183,364,000 | 162,386,000 | 142,048,000 | 133,138,000 | 112,946,000 | 129,660,000 | 107,599,000 | 95,122,000 | ||
| current debt | 34,945,000 | 34,924,000 | |||||||||||||||
| total current liabilities | 1,249,088,000 | 1,374,701,000 | 1,152,006,000 | 1,409,157,000 | 1,387,313,000 | 1,526,648,000 | 977,156,000 | 1,301,325,000 | 972,609,000 | 535,091,000 | 658,226,000 | 605,086,000 | 610,461,000 | 356,960,000 | 422,781,000 | 412,330,000 | 372,106,000 |
| long-term debt | |||||||||||||||||
| other liabilities | 54,878,000 | 57,906,000 | 76,121,000 | 72,498,000 | 72,775,000 | 71,495,000 | 70,381,000 | 70,370,000 | 78,571,000 | 83,286,000 | 87,207,000 | 91,122,000 | 91,101,000 | 94,295,000 | 90,272,000 | 93,264,000 | 91,264,000 |
| total liabilities | 1,303,966,000 | 1,432,607,000 | 1,263,031,000 | 1,516,539,000 | 1,487,448,000 | 1,627,977,000 | 1,079,845,000 | 1,406,475,000 | 1,088,429,000 | 656,859,000 | 785,146,000 | 737,151,000 | 743,734,000 | 494,656,000 | 557,681,000 | 551,456,000 | 562,782,000 |
| commitments and contingencies | |||||||||||||||||
| stockholders' equity | |||||||||||||||||
| common stock | 4,143,000 | 4,130,000 | 4,122,000 | 4,120,000 | 4,114,000 | 4,108,000 | 4,064,000 | 4,060,000 | 4,145,000 | 4,124,000 | 4,117,000 | 4,082,000 | 4,057,000 | 4,001,000 | 3,915,000 | 3,909,000 | 2,494,000 |
| additional paid-in capital | 2,083,234,000 | 2,070,446,000 | 2,053,895,000 | 2,051,638,000 | 2,038,540,000 | 2,020,803,000 | 1,986,899,000 | 1,970,930,000 | 2,130,126,000 | 2,106,886,000 | 2,094,562,000 | 2,076,329,000 | 2,064,242,000 | 2,045,572,000 | 2,024,764,000 | 2,011,651,000 | 265,603,000 |
| accumulated deficit | -1,679,235,000 | -1,574,865,000 | -1,586,977,000 | -1,481,187,000 | -1,363,572,000 | -1,332,890,000 | -1,326,826,000 | -1,096,393,000 | -1,048,208,000 | -1,064,230,000 | -1,007,764,000 | -977,096,000 | -956,447,000 | -957,677,000 | -900,956,000 | -865,113,000 | -566,268,000 |
| accumulated other comprehensive income | 787,000 | 543,000 | -88,000 | 301,000 | -2,447,000 | -2,747,000 | -2,298,000 | -6,230,000 | -3,549,000 | -5,560,000 | -5,098,000 | 513,000 | |||||
| total stockholders’ equity | 408,929,000 | 500,254,000 | 470,952,000 | 574,872,000 | 675,867,000 | 688,486,000 | 661,021,000 | 871,600,000 | 1,081,840,000 | 1,040,609,000 | 1,085,289,000 | 1,103,371,000 | 1,111,477,000 | 1,091,596,000 | 1,127,439,000 | 1,150,278,000 | -298,244,000 |
| total liabilities and stockholders’ equity | 1,712,895,000 | 1,932,861,000 | 1,733,983,000 | 2,091,411,000 | 2,163,315,000 | 2,316,463,000 | 1,740,866,000 | 2,278,075,000 | 2,170,269,000 | 1,697,468,000 | 1,870,435,000 | 1,840,522,000 | 1,855,211,000 | ||||
| accounts payable, accrued expenses and other | 220,342,000 | 218,492,000 | |||||||||||||||
| long-term debt, net of current portion | 34,904,000 | 34,884,000 | 27,360,000 | 29,834,000 | 32,308,000 | 34,780,000 | 37,249,000 | 38,482,000 | 39,713,000 | 40,943,000 | 42,172,000 | 43,401,000 | 44,628,000 | 45,862,000 | 99,412,000 | ||
| total agilon health, inc. stockholders' equity | 470,952,000 | 574,872,000 | 676,635,000 | 689,274,000 | 661,839,000 | 872,367,000 | 1,082,514,000 | 1,041,220,000 | 1,085,817,000 | 1,103,828,000 | 1,111,852,000 | 1,091,896,000 | 1,127,723,000 | 1,150,447,000 | -298,171,000 | ||
| noncontrolling interests | -768,000 | -788,000 | -818,000 | -767,000 | -674,000 | -611,000 | -528,000 | -457,000 | -375,000 | -300,000 | -284,000 | -169,000 | -73,000 | ||||
| current portion of long-term debt | 8,750,000 | 7,500,000 | 6,250,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 | 3,750,000 | |||||
| current assets of discontinued operations | |||||||||||||||||
| non-current assets of discontinued operations | |||||||||||||||||
| current liabilities of discontinued operations | |||||||||||||||||
| non-current liabilities of discontinued operations | |||||||||||||||||
| current assets held for sale and discontinued operations | |||||||||||||||||
| liabilities, contingently redeemable common stock and stockholders’ equity | |||||||||||||||||
| current liabilities held for sale and discontinued operations | |||||||||||||||||
| contingently redeemable common stock, 0.01 par value: 76,201 shares issued and outstanding at december 31, 2020 | |||||||||||||||||
| total liabilities, contingently redeemable common stock and stockholders’ equity | 1,586,252,000 | 1,685,120,000 | 1,701,734,000 | 574,038,000 | |||||||||||||
| mezzanine equity: | |||||||||||||||||
| non-current assets held for sale | 1,199,000 | ||||||||||||||||
| contingently redeemable common stock, 0.01 par value: 76,201 shares issued and outstanding | 309,500,000 |
We provide you with 20 years of balance sheets for agilon health inc. stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of agilon health inc.. Explore the full financial landscape of agilon health inc. stock with our expertly curated balance sheets.
The information provided in this report about agilon health inc. stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.